Publications in collaboration with researchers from University of Pennsylvania (25)

2017

  1. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150

  2. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266

  3. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard

    Arthritis and Rheumatology, Vol. 69, Núm. 2, pp. 429-438

2016

  1. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

    Arthritis Care and Research, Vol. 68, Núm. 5, pp. 667-672

  2. Diagnostic arthrocentesis for suspicion of gout is safe and well tolerated

    Journal of Rheumatology, Vol. 43, Núm. 1, pp. 150-153

  3. Performance of classification criteria for gout in early and established disease

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 178-182

  4. Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard

    Arthritis Care and Research, Vol. 68, Núm. 12, pp. 1894-1898

2015

  1. 2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    Arthritis and Rheumatology, Vol. 67, Núm. 10, pp. 2557-2568

  2. 2015 Gout classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1789-1798

  3. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 385, Núm. 9963, pp. 117-171

  4. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323

  5. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition

    The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191

  6. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 9995, pp. 743-800

  7. Study for updated gout classification criteria: Identification of features to classify gout

    Arthritis Care and Research, Vol. 67, Núm. 9, pp. 1304-1315

2012

  1. 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1431-1446

  2. 2012 American college of rheumatology guidelines for management of gout. part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1447-1461

  3. Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2129-2143

  4. Developing a provisional definition of flare in patients with established gout

    Arthritis and Rheumatism, Vol. 64, Núm. 5, pp. 1508-1517

  5. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  6. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: A randomized controlled trial

    Journal of Rheumatology, Vol. 39, Núm. 9, pp. 1859-1866